FOSAMPRENAVIR vs FOSFOMYCIN TROMETHAMINE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
FOSAMPRENAVIR vs FOSFOMYCIN TROMETHAMINE: Safety Overview
| Metric | FOSAMPRENAVIR | FOSFOMYCIN TROMETHAMINE |
|---|---|---|
| Total FAERS Reports | 460 | 778 |
| Deaths Reported | 31 | 24 |
| Death Rate | 6.7% | 3.1% |
| Hospitalizations | 91 | 280 |
| Average Patient Age | 45.3 yrs | 59.2 yrs |
| % Female Patients | 27.9% | 83.9% |
| FDA Approval Date | Apr 15, 2016 | Dec 19, 1996 |
| Manufacturer | Sun Pharmaceutical Industries, Inc. | Cipla USA Inc. |
| Route | ORAL | ORAL |
| Marketing Status | Discontinued | Discontinued |